- Why Car Prices Vary From City To City
- Big Bank Phobia: Not Too Big to Fail
- Expect Your Health Care in Retirement to Hit $200,000
- Biotech Stock Mailbag: Vical, Sangamo, Spectrum Pharma
- 5 Worst Home Renovation Projects
Jim Cramer tells TheStreet's Debra Borchardt that investors should stay long on Sprint stock.
03:00PM 04/15/13
Crowd-fund This: Old Dog, New Blog
Crowd-funding is a larger part of the conversation now after the first anniversary of the much maligned JOBS Act. But the Urken siblings teach Jim Cramer how to raise money at home through Kickstarter, Indiegogo, Crowdtilt and Crowdrise.
01:19PM 04/15/13
Mad Money Uncovered: Merck and the Pharma Laggards
Jim Cramer looks at why he is highlighting pharma along with growth biotech, with Nicole Urken, Mad Money Research Associate.
12:13PM 04/15/13
Cramer: Jobs, Inflation Report Are Encouraging
Jim Cramer is encouraged by the positive move in the jobless claims and inflation numbers. He tells TheStreet's Debra Borchardt about the stocks like Panera that will thrive.
03:00PM 04/11/13
Cramer: $48 JP Morgan Is My Sweet Spot
JP Morgan reports earnings on Friday. Jim Cramer tells TheStreet's Debra Borchardt that he'd buy it at $48.
03:00PM 04/11/13
Cramer: Microsoft Is Not a Sell
Jim Cramer does not agree with Goldman Sachs' downgrade of Microsoft. He tells TheStreet's Debra Borchardt he thinks it's a good stock for trading the range.
11:59AM 04/11/13
Dan Dicker talks with Jim Cramer about the short squeeze move of First Solar on Tuesday and whether it signals the return of the solar trade
02:22PM 04/10/13
Mad Money Uncovered: The Demise of JC Penney
Jim Cramer looks at the fall of JC Penney under Ron Johnson with Nicole Urken, Mad Money Research Director
12:47PM 04/10/13
Cramer: Gold Coins Not Gold ETF's
Jim Cramer tells TheStreet's Debra Borchardt he prefers gold coins over gold ETF's. 'It's cheaper now than it has been in years.'
07:00AM 04/09/13
RSS Feed